Media headlines about Quotient (NASDAQ:QTNT) have trended somewhat positive on Monday, Accern reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Quotient earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.2472075659643 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Several equities research analysts recently weighed in on the company. Zacks Investment Research lowered Quotient from a “hold” rating to a “sell” rating in a research report on Thursday, November 2nd. Jefferies Group lowered their price objective on Quotient from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, November 1st. Finally, BTIG Research reiterated a “buy” rating and set a $12.00 price objective on shares of Quotient in a research note on Wednesday, November 1st.
Quotient (QTNT) traded up $0.04 during mid-day trading on Monday, hitting $4.12. The stock had a trading volume of 485,500 shares, compared to its average volume of 512,133. Quotient has a 52-week low of $3.22 and a 52-week high of $7.74. The company has a quick ratio of 0.86, a current ratio of 1.36 and a debt-to-equity ratio of -5.17. The stock has a market capitalization of $187.70, a PE ratio of -1.43 and a beta of 1.40.
In related news, insider D J. Paul E. Cowan sold 100,000 shares of the company’s stock in a transaction on Wednesday, October 18th. The stock was sold at an average price of $4.64, for a total transaction of $464,000.00. Following the completion of the sale, the insider now owns 26,666 shares in the company, valued at $123,730.24. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider D J. Paul E. Cowan sold 45,000 shares of the business’s stock in a transaction dated Tuesday, October 17th. The shares were sold at an average price of $4.55, for a total value of $204,750.00. Following the sale, the insider now directly owns 26,666 shares of the company’s stock, valued at approximately $121,330.30. The disclosure for this sale can be found here. 29.00% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Quotient (QTNT) Earns Daily Media Sentiment Rating of 0.13” was published by BBNS and is owned by of BBNS. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://baseballnewssource.com/markets/quotient-qtnt-receiving-somewhat-favorable-news-coverage-analysis-finds/1818374.html.
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.